Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-Results Survey on Long-Term Treatment for Prograf® Capsules 0.5 mg, 1 mg Lupus Nephritis

NCT01410747 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01410747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01410747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-Results Survey on Long-Term Treatment for Prograf® Capsules 0.5 mg, 1 mg Lupus Nephritis
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
April 10, 2007
Completion date
January 31, 2020
Enrollment
1,484 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis